TPTE and esophageal squamous cell carcinoma: During the clinical study, the following TAAs for melanoma were utilized: New York esophageal squamous cell carcinoma 1 (NY-ESO-1), melanoma-associated antigen A3 (MAGE-A3), tyrosinase, and transmembrane phosphatase with tensin homology (TPTE).